Page 4 - Adjupharm Gmbh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adjupharm gmbh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adjupharm Gmbh Today - Breaking & Trending Today

IMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients

IMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Adjupharm Gmb , Oren Shuster , Anna Taranko , Company Contacts , Trichome Financial Corp , Source Im Cannabis Corp , Herbs Ltd , Im Cannabis Corp , Canadian Securities Exchange , Prnewswire Im Cannabis Corp , Ministry Of Health , Israeli Ministry Of Health , Israeli Ministry , Chief Executive Officer , Focus Medical Herbs Ltd , Adjupharm Gmbh , Highland Grow , Focus Medical , Director Investor , Chief Executive ,

IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity - IM Cannabis (NASDAQ:IMCC)

IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial and operational results for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on Israel and Germany reported a 10% year-over-year decrease in revenue to CA$48.8 million ($36 million) in 2023. IM Cannabis attributed it to "negative currency fluctuations and the impact of the Israel-Hamas war on the company's operations." Fourth quarter revenue dropped 26% year-over-year to CA$10.7 million. "As previously warned and as expected, unfortunately, the Israel-Hamas war had a negative impact on our fourth quarter 2023 results, which weighed on our full-year results.," Uri Birenberg, chief financial officer of IMC, said. "Coupled with our fourth quarter of 2023 inventory reduction, the war caused our fourth quarter gross profit to decrease by 68% as compared to the fourth quarter of 2022." ....

Adjupharm Gmb , Oren Shuster , Im Cannabis Corp , Uri Birenberg , Adjupharm Gmbh , Cannabis Capital Conference ,